Morgan Stanley Biodesix Inc Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in Biodesix Inc stock. As of the latest transaction made, Morgan Stanley holds 12,876 shares of BDSX stock, worth $5,150. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,876

Previous 40,276 68.03%

Holding current value

$5,150

Previous $60,000 86.67%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$0.63 - $1.52 $17,262 - $41,648	-27,400 Reduced 68.03%	12,876 $8,000
Q4 2024 Feb 14, 2025	BUY	$1.16 - $1.76 $38,095 - $57,800	32,841 Added 441.71%	40,276 $60,000
Q2 2024 May 14, 2025	SELL	$1.21 - $1.71 $39,737 - $56,158	-32,841 Reduced 81.54%	7,435 $11,000
Q2 2024 Oct 17, 2024	SELL	$1.21 - $1.71 $2,102 - $2,971	-1,738 Reduced 18.95%	7,435 $11,000
Q2 2024 Aug 14, 2024	SELL	$1.21 - $1.71 $2,102 - $2,971	-1,738 Reduced 18.95%	7,435 $11,000
Q1 2024 Oct 17, 2024	BUY	$1.35 - $2.12 $2,346 - $3,684	1,738 Added 23.38%	9,173 $13,000
Q1 2024 Aug 16, 2024	SELL	$1.35 - $2.12 $1,298 - $2,039	-962 Reduced 9.49%	9,173 $13,000
Q1 2024 May 15, 2024	SELL	$1.35 - $2.12 $1,298 - $2,039	-962 Reduced 9.49%	9,173 $13,000
Q4 2023 Aug 16, 2024	BUY	$1.2 - $2.13 $3,240 - $5,751	2,700 Added 36.31%	10,135 $18,000
Q4 2023 Feb 13, 2024	SELL	$1.2 - $2.13 $660 - $1,171	-550 Reduced 5.15%	10,135 $18,000
Q3 2023 Nov 15, 2023	SELL	$1.04 - $1.74 $8,780 - $14,690	-8,443 Reduced 44.14%	10,685 $17,000
Q2 2023 Aug 14, 2023	SELL	$1.12 - $1.88 $35,920 - $60,295	-32,072 Reduced 62.64%	19,128 $23,000
Q1 2023 May 15, 2023	SELL	$1.52 - $2.5 $1,515 - $2,492	-997 Reduced 1.91%	51,200 $95,000
Q4 2022 Feb 14, 2023	SELL	$0.98 - $2.3 $4,668 - $10,957	-4,764 Reduced 8.36%	52,197 $120,000
Q3 2022 Nov 14, 2022	SELL	$1.24 - $2.89 $20,990 - $48,921	-16,928 Reduced 22.91%	56,961 $71,000
Q2 2022 Oct 27, 2022	BUY	$1.32 - $2.12 $23,795 - $38,217	18,027 Added 32.27%	73,889 $122,000
Q2 2022 Aug 15, 2022	BUY	$1.32 - $2.12 $23,795 - $38,217	18,027 Added 32.27%	73,889 $122,000
Q1 2022 Oct 27, 2022	SELL	$1.69 - $5.81 $30,465 - $104,736	-18,027 Reduced 24.4%	55,862 $94,000
Q1 2022 May 13, 2022	SELL	$1.69 - $5.81 $15,941 - $54,805	-9,433 Reduced 14.45%	55,862 $94,000
Q4 2021 Feb 14, 2022	SELL	$4.09 - $8.67 $176,802 - $374,786	-43,228 Reduced 39.83%	65,295 $345,000
Q3 2021 Nov 15, 2021	BUY	$6.6 - $12.78 $716,251 - $1.39 Million	108,523 New	108,523 $892,000

Others Institutions Holding BDSX

# of Institutions

Shares Held

47.7M

Call Options Held

65.5K

Put Options Held

500

View Full List

About BIODESIX INC

Ticker BDSX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 39,982,000
Market Cap $16M
Description
Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...

More about BDSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account